{"columns":[{"name":"Goal","type":"string"},{"name":"Target","type":"string"},{"name":"Indicator","type":"string"},{"name":"SeriesCode","type":"string"},{"name":"SeriesDescription","type":"string"},{"name":"GeoAreaCode","type":"string"},{"name":"GeoAreaName","type":"string"},{"name":"TimePeriod","type":"string"},{"name":"Value","type":"string"},{"name":"Time_Detail","type":"string"},{"name":"TimeCoverage","type":"string"},{"name":"UpperBound","type":"string"},{"name":"LowerBound","type":"string"},{"name":"BasePeriod","type":"string"},{"name":"Source","type":"string"},{"name":"GeoInfoUrl","type":"string"},{"name":"FootNote","type":"string"},{"name":"[Nature]","type":"string"},{"name":"[Reporting Type]","type":"string"},{"name":"[Units]","type":"string"}],"n_rows":5621,"rows_kept":5621,"cut":false,"text_format":"parquet-jsonl-2026-10-02","bounds":{"document_bytes":16777216,"package_text_limit_bytes":33554432,"package_text_slack_bytes":1024,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096,"vector_min":64,"vector_head_fixed":16,"vector_head_variable":64,"kv_value_chars":1048576,"nesting_max":64,"binary_text":true},"cells_cut":0,"cells_bad_utf8":0,"cells_raw":0,"cells_binary":0,"cells_binary_text":0,"cells_vector":0,"n_row_groups":1,"reader":"pyarrow 23.0.1, python 3.13","created_by":"DuckDB version v1.2.2 (build 7c039464e4)","schema":{"fields":[{"name":"Goal","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Target","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Indicator","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"SeriesDescription","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaCode","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoAreaName","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Value","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Time_Detail","type":"string","nullable":true,"metadata":null,"children":null},{"name":"TimeCoverage","type":"string","nullable":true,"metadata":null,"children":null},{"name":"UpperBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"LowerBound","type":"string","nullable":true,"metadata":null,"children":null},{"name":"BasePeriod","type":"string","nullable":true,"metadata":null,"children":null},{"name":"Source","type":"string","nullable":true,"metadata":null,"children":null},{"name":"GeoInfoUrl","type":"string","nullable":true,"metadata":null,"children":null},{"name":"FootNote","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Nature]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Reporting Type]","type":"string","nullable":true,"metadata":null,"children":null},{"name":"[Units]","type":"string","nullable":true,"metadata":null,"children":null}],"parquet":"required group field_id=-1 duckdb_schema {\n  optional binary field_id=-1 Goal (String);\n  optional binary field_id=-1 Target (String);\n  optional binary field_id=-1 Indicator (String);\n  optional binary field_id=-1 SeriesCode (String);\n  optional binary field_id=-1 SeriesDescription (String);\n  optional binary field_id=-1 GeoAreaCode (String);\n  optional binary field_id=-1 GeoAreaName (String);\n  optional binary field_id=-1 TimePeriod (String);\n  optional binary field_id=-1 Value (String);\n  optional binary field_id=-1 Time_Detail (String);\n  optional binary field_id=-1 TimeCoverage (String);\n  optional binary field_id=-1 UpperBound (String);\n  optional binary field_id=-1 LowerBound (String);\n  optional binary field_id=-1 BasePeriod (String);\n  optional binary field_id=-1 Source (String);\n  optional binary field_id=-1 GeoInfoUrl (String);\n  optional binary field_id=-1 FootNote (String);\n  optional binary field_id=-1 [Nature] (String);\n  optional binary field_id=-1 [Reporting Type] (String);\n  optional binary field_id=-1 [Units] (String);\n}\n"},"kv_metadata":[]}
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2023","18","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2000","70","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2001","50","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2002","61","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2003","88","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2004","86","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2009","61","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2021","67","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2022","51","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","184","Cook Islands","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2008","89","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2009","84","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2010","79","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2011","80","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2021","69","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2022","75","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","188","Costa Rica","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2000","17","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2001","19","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2002","20","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2003","20","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2004","22","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2005","32","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2006","34","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2007","35","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2008","37","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2009","40","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2010","41","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2011","48","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2023","62","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2000","86","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2001","88","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2002","93","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","191","Croatia","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2012","52","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2013","56","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2014","59","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2015","63","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2016","67","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2017","68","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2018","70","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2019","71","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2021","71","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","1","World","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2005","53","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2009","95","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","192","Cuba","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2000","12","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2001","12","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2002","11","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2003","11","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2004","13","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2005","13","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2006","13","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2007","13","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2008","11","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2009","11","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2010","11","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2011","11","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","643","Russian Federation","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2007","93","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2008","89","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2009","88","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2010","88","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2011","88","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2012","88","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2014","88","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2012","13","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2013","15","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2014","19","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2015","26","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2016","30","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2017","32","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2018","33","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2019","39","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2020","44","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2021","45","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2022","47","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","2","Africa","2023","52","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","646","Rwanda","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2022","88","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","196","Cyprus","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2001","0","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2004","2","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2005","9","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2006","18","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2007","4","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2008","23","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2009","24","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2002","0","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2003","0","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2004","0","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2005","1","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2006","2","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2007","1","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2008","4","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2009","5","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2010","5","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2011","6","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2012","12","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2013","19","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2014","23","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2015","29","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2016","34","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2017","36","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2018","38","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2019","44","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2020","44","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2021","43","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2022","47","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","199","Least Developed Countries (LDCs)","2023","51","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2000","3","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2001","2","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2002","2","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2003","2","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2004","2","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2005","2","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2006","2","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2007","2","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2008","2","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2009","3","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2010","2","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2011","2","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2012","4","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2013","4","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2014","8","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2015","15","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2016","20","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2017","22","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2018","23","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2019","31","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2020","38","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2021","38","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","659","Saint Kitts and Nevis","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2000","89","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2001","73","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2002","71","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2003","69","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2004","67","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2005","56","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2006","45","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2007","33","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2008","22","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2010","29","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2011","31","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2012","33","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2013","38","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2014","44","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2015","42","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2016","40","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2017","38","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2018","46","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2019","37","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2020","38","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2022","42","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","202","Sub-Saharan Africa","2023","48","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2009","63","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2010","74","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2011","72","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2012","80","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2013","62","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2014","79","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2017","73","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2018","68","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2021","66","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2022","63","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","662","Saint Lucia","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2003","86","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2004","73","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2005","93","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2006","88","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2021","37","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2022","42","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","4","Afghanistan","2023","42","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2000","61","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2001","61","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2002","58","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2003","52","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2004","53","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2005","50","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2006","50","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2007","48","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2007","83","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2009","94","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2008","49","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2009","57","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2010","59","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2011","68","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2012","67","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2013","65","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2014","77","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2015","75","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2016","74","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2017","70","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2018","75","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2019","62","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2020","55","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2021","59","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","5","South America","2023","63","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2001","90","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2002","93","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2003","93","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","670","Saint Vincent and the Grenadines","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2003","94","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","203","Czechia","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","8","Albania","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2000","0","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2001","1","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2002","2","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2003","2","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2004","41","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2005","43","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2006","44","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2007","45","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2008","41","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2009","42","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2010","45","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2011","55","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2012","55","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2013","56","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2014","56","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2015","56","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2016","56","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2017","56","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2004","94","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2005","94","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2007","94","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2008","92","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2010","90","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2013","85","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2016","81","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2019","79","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2021","81","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","674","San Marino","2023","79","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2018","57","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2019","64","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2020","66","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2021","62","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","9","Oceania","2023","70","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2011","0","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2012","4","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","204","Benin","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2014","71","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2015","76","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2016","76","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2017","76","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2018","76","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2021","69","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","678","Sao Tome and Principe","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2001","96","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2013","4","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2014","7","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2015","12","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2016","14","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2017","15","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2018","16","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2019","23","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2020","39","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2021","40","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2022","41","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","11","Western Africa","2023","47","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2001","87","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2002","92","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2003","88","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2004","88","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2005","91","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2006","91","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2007","88","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2008","87","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2009","85","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2010","85","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2011","86","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2012","87","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2014","84","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","208","Denmark","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2001","62","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2009","95","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","682","Saudi Arabia","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2000","78","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2001","73","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2002","93","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2004","94","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2005","94","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2018","77","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2021","73","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","12","Algeria","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2000","70","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2001","70","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2002","63","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2003","71","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2004","72","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2005","73","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2006","68","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2007","64","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2008","72","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2009","71","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2010","69","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2014","13","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2015","54","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","212","Dominica","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2011","74","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2012","71","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2013","59","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2014","73","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2015","74","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2017","64","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2019","64","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2016","57","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2017","59","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2018","62","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2019","63","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2020","63","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2021","64","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","686","Senegal","2023","64","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2000","78","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2001","74","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2002","75","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","13","Central America","2023","75","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2001","0","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2002","0","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2003","0","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2004","0","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2005","0","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2006","0","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2007","0","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2008","0","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2006","90","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2009","87","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2013","82","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2009","0","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2010","0","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2011","0","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2012","0","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2013","2","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2014","8","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2015","18","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2016","29","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2017","31","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2018","33","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2019","45","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2020","46","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2021","46","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2022","54","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","14","Eastern Africa","2023","56","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2000","54","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2001","56","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2002","57","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2003","58","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2004","68","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2005","69","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2006","69","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2007","68","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2008","56","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2009","57","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2010","57","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2011","61","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2012","65","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2013","74","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2014","82","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2018","31","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","688","Serbia","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2018","86","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","15","Northern Africa","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2019","60","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2020","55","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2021","60","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2022","65","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","214","Dominican Republic","2023","70","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2012","81","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2013","70","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2014","59","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2015","76","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2016","64","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2017","73","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2020","70","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2021","58","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2022","60","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","218","Ecuador","2023","60","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2014","0","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2015","3","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2016","3","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2017","3","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2018","4","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2019","6","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2020","9","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2021","8","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2022","10","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","17","Middle Africa","2023","26","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2003","77","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2004","80","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2005","85","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2006","89","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2007","86","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2008","79","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2009","82","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2010","78","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2011","81","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2013","85","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2014","85","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2017","86","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2018","85","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2020","66","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2021","80","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","222","El Salvador","2023","71","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2000","53","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2001","48","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2002","44","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2003","49","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2004","48","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2005","46","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2006","51","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2007","48","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2008","52","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2009","59","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2010","53","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","690","Seychelles","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2011","51","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2012","50","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2013","51","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2014","55","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2015","58","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2016","66","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2017","75","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2019","78","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2021","80","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2015","60","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2016","50","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2017","55","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2018","64","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2020","67","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","18","Southern Africa","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2000","65","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2001","66","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2002","63","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2003","61","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2004","63","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2005","62","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2006","61","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2007","60","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2008","62","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2009","66","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2021","67","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","694","Sierra Leone","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2001","96","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2010","67","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2011","72","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2012","73","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2013","70","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2014","78","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2015","78","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2016","80","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2017","75","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2020","73","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2021","77","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2010","96","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2013","90","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","702","Singapore","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","703","Slovakia","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2022","76","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","19","Americas","2023","75","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2021","17","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2022","13","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","226","Equatorial Guinea","2023","28","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2007","18","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2011","93","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2012","83","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2022","81","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","704","Viet Nam","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2010","96","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2007","80","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2008","86","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2009","82","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2010","86","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2019","41","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2020","46","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2021","46","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2022","48","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","231","Ethiopia","2023","53","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","705","Slovenia","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","20","Andorra","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2000","78","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2001","79","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2002","79","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2003","79","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2004","79","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2005","79","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2018","85","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","232","Eritrea","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2000","89","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2001","84","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2002","94","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2021","4","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2022","8","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2006","79","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2007","79","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2008","80","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2009","81","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2010","81","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","21","Northern America","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","706","Somalia","2023","13","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2000","62","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2001","54","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2002","46","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2003","52","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2004","51","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2005","48","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2006","53","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2007","49","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2008","54","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2009","63","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2015","16","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2016","16","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2017","18","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2018","23","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2019","33","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2020","29","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2021","22","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2022","25","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","233","Estonia","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2010","55","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2011","54","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2012","53","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2013","50","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2014","55","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2015","59","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2016","69","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2018","75","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2019","79","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2020","76","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","24","Angola","2023","35","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2005","46","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2006","68","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2007","78","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2008","83","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","710","South Africa","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2005","74","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2007","94","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2008","93","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2011","93","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2009","94","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2010","92","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2011","89","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2013","87","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2015","84","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2016","68","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2020","80","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2021","76","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","28","Antigua and Barbuda","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2000","1","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2001","11","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2002","11","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2003","11","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2004","12","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2005","23","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2006","32","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2007","32","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2008","31","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2009","30","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2010","28","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2011","27","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2012","27","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2013","26","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2014","27","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2015","28","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2016","38","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2017","39","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2018","53","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2017","86","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2021","78","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","242","Fiji","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2019","63","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2020","61","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2021","62","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","29","Caribbean","2023","65","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2000","2","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2001","3","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2002","3","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2003","3","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2004","4","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2005","77","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2018","78","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2021","76","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2022","77","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","716","Zimbabwe","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2000","5","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2001","14","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2002","14","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2006","86","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2007","85","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2003","13","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2004","15","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2005","23","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2006","28","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2007","29","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2008","28","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2009","27","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2010","26","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2011","26","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2012","26","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2013","26","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2014","26","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2015","27","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2016","33","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2017","34","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2018","43","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2019","53","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2020","52","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2021","51","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2022","56","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","722","Small island developing States (SIDS)","2023","61","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2004","91","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2009","90","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2010","92","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","724","Spain","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","30","Eastern Asia","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2001","65","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2002","67","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2003","66","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","246","Finland","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2010","61","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2011","67","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2012","72","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2013","75","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2014","77","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2015","79","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","728","South Sudan","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2004","67","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2005","67","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2006","68","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2007","75","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2008","79","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2009","83","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2012","24","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2013","57","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2014","61","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2015","69","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2016","69","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2017","72","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2021","63","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2022","51","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","729","Sudan","2023","38","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","31","Azerbaijan","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2000","56","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2001","56","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2002","83","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2003","80","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2016","80","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","250","France","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2013","82","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2014","82","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2016","81","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2017","81","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2020","60","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2021","48","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2022","48","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","262","Djibouti","2023","64","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2013","15","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2014","15","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2015","21","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2016","34","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2017","32","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2018","31","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2019","32","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2020","24","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2004","93","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2005","88","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2006","91","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2007","84","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2008","88","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2013","83","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2021","43","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2022","51","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","740","Suriname","2023","52","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2000","36","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2001","61","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2002","60","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2003","62","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2004","67","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2005","71","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2006","69","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2007","72","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","32","Argentina","2023","54","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2000","3","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2001","3","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2002","3","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2003","3","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2008","67","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2009","68","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2010","68","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2011","70","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2012","70","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2013","75","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2014","79","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2016","84","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2004","4","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2005","4","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2006","4","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2007","4","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2008","5","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2009","9","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2010","10","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2011","29","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2012","39","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2013","53","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2014","61","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2015","68","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2016","75","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2017","78","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2018","80","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","34","Southern Asia","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2000","9","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2001","8","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2002","9","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2003","17","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2004","21","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2005","22","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2006","33","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2007","44","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2008","56","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2009","61","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2010","62","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2011","69","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2012","70","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","266","Gabon","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2001","8","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2002","40","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2013","73","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2014","55","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2015","57","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2016","69","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2017","72","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2021","61","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","35","South-Eastern Asia","2023","70","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2021","81","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","747","Northern Africa and Western Asia","2023","79","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2003","57","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2004","75","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2005","87","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2006","88","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2008","87","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2009","71","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2010","84","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2011","77","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2012","79","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2014","87","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2004","85","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2005","85","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2006","87","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2007","89","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2008","80","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2009","82","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2012","52","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2016","76","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2017","70","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2018","75","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2020","70","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2021","69","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2022","77","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","748","Eswatini","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2000","94","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2001","94","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2002","94","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2003","95","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2010","88","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2006","95","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2009","95","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","752","Sweden","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2000","5","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2001","5","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2002","5","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2003","9","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2004","10","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2020","77","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2021","81","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2022","78","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","268","Georgia","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","36","Australia","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2000","16","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2001","23","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2002","23","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2003","25","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2004","51","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2005","52","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2006","52","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2007","58","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2008","58","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2005","56","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2006","66","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2007","70","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2008","79","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2009","84","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2010","85","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2011","87","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2012","88","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2012","56","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2013","53","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2014","73","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2015","81","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2016","79","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2017","68","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2018","71","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2019","61","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2020","61","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2021","61","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","753","Eastern and South-Eastern Asia","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2009","56","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2010","57","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2011","57","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2012","57","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2022","88","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","39","Southern Europe","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2000","35","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2001","34","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2002","39","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2003","46","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2004","47","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2005","54","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2006","61","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2022","52","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","270","Gambia","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2000","95","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2001","94","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2002","93","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2003","94","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2004","94","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2006","92","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2007","87","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2005","71","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2006","71","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2007","71","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2008","83","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2009","83","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2010","83","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2011","86","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2007","56","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2008","62","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2009","64","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2010","69","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2011","73","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2012","78","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2013","82","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2014","87","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2012","86","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2014","87","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","275","State of Palestine","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2002","77","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2003","83","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2004","89","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2005","91","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2006","90","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2008","92","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2011","93","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","40","Austria","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2005","88","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2006","88","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2007","84","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2008","80","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2009","76","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2010","78","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2011","79","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2012","73","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2013","69","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2014","72","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2015","76","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2016","74","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2017","76","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2018","69","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2021","80","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2022","65","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","44","Bahamas","2023","53","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2000","92","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2002","97","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","48","Bahrain","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","276","Germany","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2012","52","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2013","54","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","756","Switzerland","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2000","80","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2001","83","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2002","84","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2003","83","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2004","82","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2005","81","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2006","81","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2007","81","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2008","81","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2009","82","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2012","41","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2013","82","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","50","Bangladesh","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2000","94","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2014","67","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2015","63","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2016","75","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","288","Ghana","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2009","35","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2010","82","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2011","76","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2012","64","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2013","62","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2014","60","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2015","58","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2017","70","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2018","65","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2019","65","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2020","64","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2021","64","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2022","49","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","760","Syrian Arab Republic","2023","64","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2000","59","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2001","72","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2002","93","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2003","94","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2007","90","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2001","96","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2002","95","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2003","93","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2004","94","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2006","85","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2007","93","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2008","87","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","51","Armenia","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","762","Tajikistan","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2001","86","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2002","89","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2003","92","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2007","94","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2001","12","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2002","41","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2003","71","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2010","96","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2008","91","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2009","91","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2017","77","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2019","77","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2020","78","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","52","Barbados","2023","76","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2004","70","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2005","70","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2006","71","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2007","73","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2008","65","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2009","67","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2010","72","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","764","Thailand","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2010","21","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2011","61","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2012","9","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2014","80","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2015","76","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2016","79","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2018","85","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2020","57","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2021","58","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2011","89","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2019","53","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2020","46","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2021","50","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2022","57","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","768","Togo","2023","58","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","776","Tonga","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2022","68","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","296","Kiribati","2023","47","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2007","77","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2008","77","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2009","77","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2010","77","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2011","77","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2012","83","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2013","83","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2016","83","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","53","Australia and New Zealand","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2005","6","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2006","7","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2007","7","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2008","7","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2009","7","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2010","7","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2011","7","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2012","7","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2013","7","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2014","6","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2015","6","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2016","6","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2017","6","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2018","10","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2019","25","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2020","31","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2021","24","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2022","32","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","54","Melanesia","2023","43","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2001","80","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2002","77","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2003","73","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2004","78","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2005","84","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2006","78","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2007","87","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2008","81","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2009","80","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2010","82","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2011","83","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2012","85","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2015","79","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2016","65","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","300","Greece","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2002","74","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2003","68","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2004","61","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2005","81","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","780","Trinidad and Tobago","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2000","92","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2001","92","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2002","92","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2003","92","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2004","92","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2005","94","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2006","93","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2007","93","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2008","92","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2006","78","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2007","78","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2008","81","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2009","83","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2010","83","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2011","83","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2012","80","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2014","80","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","56","Belgium","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2000","24","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2001","33","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2002","46","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2003","50","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2004","53","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2005","52","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2006","51","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2007","57","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2008","52","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2009","62","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2010","59","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2011","71","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2012","46","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2014","74","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2015","75","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2016","64","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2017","68","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","784","United Arab Emirates","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2018","69","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2020","63","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2021","53","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2022","57","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","57","Micronesia","2023","57","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2000","4","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2001","5","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2002","57","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2003","77","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2004","66","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2005","55","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2006","43","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2007","61","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2008","66","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2009","45","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2010","56","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2011","68","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2012","68","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2013","83","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2014","77","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2015","70","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2016","70","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2017","70","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2018","52","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2021","65","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2022","61","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","61","Polynesia","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2000","6","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2001","6","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2002","6","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2003","6","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2004","6","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2005","6","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2006","6","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2007","6","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2008","6","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2009","11","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2010","12","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2011","31","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2012","41","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2013","55","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2014","62","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2015","69","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","788","Tunisia","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2001","91","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2002","83","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2006","87","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2007","86","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2008","86","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2009","78","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2010","86","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2011","85","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2012","75","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2013","85","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2016","76","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","62","Central and Southern Asia","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2006","84","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2007","94","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2008","92","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2009","88","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2011","86","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2012","85","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2014","88","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2017","86","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2008","72","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2009","79","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2010","85","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2021","55","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2022","68","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","308","Grenada","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","64","Bhutan","2023","97","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","792","Türkiye","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2000","92","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2001","94","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2002","87","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2003","89","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2004","90","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2016","67","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2018","78","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2019","78","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","320","Guatemala","2023","77","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2018","38","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2019","44","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2020","46","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2021","56","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2022","49","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","68","Bolivia (Plurinational State of)","2023","50","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2000","74","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2001","86","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2002","90","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2003","85","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","795","Turkmenistan","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2002","97","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2003","93","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2004","88","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2005","90","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2006","93","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2008","92","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2009","88","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2011","88","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2004","90","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2005","86","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2006","83","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2007","74","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2008","82","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2009","84","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2010","87","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2022","3","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","324","Guinea","2023","26","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2001","88","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2002","80","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2003","71","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2020","85","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","798","Tuvalu","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2004","63","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2005","72","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2006","74","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2007","90","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2008","84","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2009","84","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2010","82","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2011","84","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2014","91","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2022","49","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","800","Uganda","2023","21","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2005","96","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2015","88","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2016","78","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2018","76","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2019","68","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2020","60","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2021","63","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2022","60","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","70","Bosnia and Herzegovina","2023","63","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2013","83","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2014","85","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2016","74","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2017","74","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2020","66","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2021","70","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2022","77","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","72","Botswana","2023","79","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2000","95","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2001","95","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2002","80","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2003","74","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2004","68","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2005","61","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2006","55","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2007","49","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2008","56","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2009","55","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2010","53","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2011","71","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2012","70","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2013","69","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2016","77","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2018","76","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2019","54","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2020","44","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2021","46","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2009","68","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2010","41","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2011","56","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2012","54","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2013","54","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2014","57","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2015","57","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2016","31","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","328","Guyana","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2022","58","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","76","Brazil","2023","64","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2005","87","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2006","92","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2007","89","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","804","Ukraine","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2000","95","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2001","94","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2002","95","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2008","90","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2021","80","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","807","North Macedonia","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2000","97","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2016","26","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2017","25","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2018","38","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2019","41","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2020","41","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2021","41","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2021","77","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2022","76","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","84","Belize","2023","88","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","818","Egypt","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2000","76","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2001","74","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2002","74","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2003","77","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2018","54","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2019","54","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2020","51","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2021","40","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","90","Solomon Islands","2023","48","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2000","95","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2022","41","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","332","Haiti","2023","41","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2004","76","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2005","75","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2006","75","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2007","74","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2008","75","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2009","79","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2010","84","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2011","85","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2012","87","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2017","88","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","826","United Kingdom of Great Britain and Northern Ireland","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2001","95","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2008","90","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2011","93","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","96","Brunei Darussalam","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2000","83","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2001","85","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2002","79","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2003","89","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2004","91","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2006","93","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2007","94","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2010","96","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","340","Honduras","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2002","99","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2014","29","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2015","53","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2016","88","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2018","68","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2019","70","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2020","64","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2021","60","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2022","73","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","834","United Republic of Tanzania","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2000","85","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2001","86","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2002","86","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2003","86","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2004","86","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","348","Hungary","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2003","92","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2004","89","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2005","90","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2006","93","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2010","92","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","100","Bulgaria","2023","87","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2005","86","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2006","86","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2007","86","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2008","87","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2009","88","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2011","90","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2021","10","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","352","Iceland","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2008","57","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2009","65","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2010","75","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2011","80","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2012","76","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2014","82","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2015","78","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2021","42","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","104","Myanmar","2023","65","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2016","94","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","840","United States of America","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2013","51","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2014","60","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2015","65","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2016","72","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2017","75","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2018","77","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2019","80","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","108","Burundi","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2000","92","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2001","97","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2006","95","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2014","17","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2015","50","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2016","59","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2017","65","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2018","71","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2019","71","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2020","71","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2021","71","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","854","Burkina Faso","2023","71","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2011","27","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2012","36","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2013","51","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2014","60","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2015","69","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2016","76","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2017","80","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2020","81","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","112","Belarus","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","356","India","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2003","21","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2004","29","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2005","23","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2006","50","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2007","73","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2008","66","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2009","67","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2010","74","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2011","76","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2012","78","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2014","28","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2015","31","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2016","55","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2017","63","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2019","71","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","858","Uruguay","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2002","97","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2005","81","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2006","63","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2007","44","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2008","26","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2009","8","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2010","54","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2020","60","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2021","53","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","360","Indonesia","2023","62","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2001","94","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2012","41","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2013","52","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2014","61","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2015","59","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2016","64","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2018","64","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2021","63","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","860","Uzbekistan","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","364","Iran (Islamic Republic of)","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2001","52","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2002","48","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2003","45","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2004","41","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","116","Cambodia","2023","64","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2009","6","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2010","31","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2011","26","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2012","33","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2005","58","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2006","52","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2007","64","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2008","76","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2009","87","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2010","77","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2011","77","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2012","68","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2013","57","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2014","67","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2015","76","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2016","75","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2019","86","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","368","Iraq","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2020","22","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2021","28","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2022","36","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","120","Cameroon","2023","45","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2013","38","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2014","50","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2015","52","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2016","53","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2017","59","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2018","39","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2019","13","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2020","28","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2021","37","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2022","30","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","862","Venezuela (Bolivarian Republic of)","2023","40","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2012","83","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2017","87","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2018","87","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","372","Ireland","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2001","97","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2002","97","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2005","96","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2007","90","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2008","91","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2002","84","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2003","65","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2004","45","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2005","26","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2006","6","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2007","36","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2008","46","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2009","14","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2010","30","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","124","Canada","2023","79","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2012","94","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2014","79","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2011","87","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2012","89","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2011","50","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2012","52","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2013","74","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2014","68","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2015","55","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2016","54","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2017","54","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2018","28","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2019","59","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2020","59","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2021","50","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2022","45","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2017","85","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","132","Cabo Verde","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","882","Samoa","2023","75","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2005","21","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2006","26","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2007","32","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2008","35","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2022","92","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","376","Israel","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2009","38","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2010","43","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2011","46","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2012","40","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2013","46","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2014","42","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2015","37","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2016","44","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2017","40","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2018","39","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2019","38","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2020","36","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2014","83","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2017","86","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","380","Italy","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2021","1","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2022","20","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","384","Côte d'Ivoire","2023","43","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2001","96","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2003","95","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2005","91","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2006","88","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2007","84","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2008","80","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2021","41","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2022","45","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","887","Yemen","2023","45","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","140","Central African Republic","2023","NaN","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2000","6","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2001","9","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2002","10","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2003","11","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2004","12","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2005","30","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2006","34","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2007","36","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2009","78","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2010","56","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2011","60","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2012","76","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2013","71","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2014","72","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2015","83","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2008","40","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2009","45","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2010","47","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2011","57","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2012","63","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2013","70","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2014","72","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2015","75","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2016","81","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2018","84","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2019","85","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2014","33","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2015","47","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","388","Jamaica","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","142","Asia","2023","85","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2000","92","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2001","93","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2005","89","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2006","82","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2007","73","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2008","78","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2015","93","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","392","Japan","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2001","95","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2003","99","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2005","96","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2008","65","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2009","58","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2010","79","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","143","Central Asia","2023","98","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2001","52","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2002","92","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2003","90","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2021","96","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2022","97","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","398","Kazakhstan","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2000","83","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2001","87","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2002","90","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2003","91","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2006","88","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2008","90","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2009","90","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","144","Sri Lanka","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2000","18","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2001","66","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2002","64","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2003","67","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2004","66","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","400","Jordan","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2005","73","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2006","69","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2007","76","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2008","78","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2009","80","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2010","80","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2011","78","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2012","74","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2014","75","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2015","76","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2016","77","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2018","78","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2019","78","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2021","78","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","145","Western Asia","2023","78","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2022","2","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","148","Chad","2023","35","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2000","50","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2001","52","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2002","64","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2003","65","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2004","70","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2005","71","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2006","72","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2007","74","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2015","28","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2016","35","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2017","41","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2018","53","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2019","60","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2020","67","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2021","71","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","404","Kenya","2023","76","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2008","74","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2009","72","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2010","78","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2011","79","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2012","80","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2014","87","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2022","89","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","150","Europe","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2000","90","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2001","91","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2002","95","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2005","96","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2008","75","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2009","75","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2010","76","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2011","76","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2012","76","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2014","76","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2015","85","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2010","89","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2013","89","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2022","0","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","408","Democratic People's Republic of Korea","2023","16","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2000","39","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2001","67","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2002","95","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2003","95","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","151","Eastern Europe","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2005","96","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2006","95","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2008","89","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2009","89","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2010","84","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2011","77","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2012","74","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2013","78","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2014","88","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2022","81","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","152","Chile","2023","70","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2000","67","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2001","72","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2002","72","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2003","74","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2017","97","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2018","97","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","410","Republic of Korea","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2004","73","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2005","73","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2006","72","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2007","72","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2008","72","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2009","74","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2010","77","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2011","77","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2012","79","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2013","80","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2014","80","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2005","77","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2007","90","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2008","86","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2009","94","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2016","85","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2018","85","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2019","84","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","154","Northern Europe","2023","83","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2000","2","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2001","2","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2002","41","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2003","44","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2004","45","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2005","48","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2006","53","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2007","53","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2008","53","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2009","53","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2010","78","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2011","81","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2012","83","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2013","84","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2014","85","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2017","87","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","155","Western Europe","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2005","84","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2019","94","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","414","Kuwait","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2000","96","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2001","98","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","156","China","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2000","84","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2001","83","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2002","93","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2003","70","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2004","70","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2005","73","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2006","85","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2007","93","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2008","70","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2009","71","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2010","74","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2011","76","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2012","80","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2013","72","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2014","88","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2019","89","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2017","96","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","417","Kyrgyzstan","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2022","84","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","170","Colombia","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2021","19","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","174","Comoros","2023","79","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2017","1","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2018","70","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2019","56","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2020","64","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2021","50","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2022","55","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","418","Lao People's Democratic Republic","2023","68","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2000","60","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2001","61","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2002","56","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2003","55","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2004","56","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2005","55","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2006","54","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2007","52","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2008","55","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2009","60","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2010","60","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2011","67","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2012","66","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2013","61","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2014","73","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2019","9","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2015","71","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2016","74","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2017","66","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2018","80","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2019","63","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2020","63","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2021","69","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2022","69","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","419","Latin America and the Caribbean","2023","67","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2000","56","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2001","42","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2020","29","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2021","31","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2022","34","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","178","Congo","2023","34","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2002","28","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2003","14","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2004","24","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2005","34","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2006","45","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2007","55","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2008","65","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2009","75","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2010","73","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2011","70","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2012","68","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2013","65","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2014","63","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2015","63","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2016","63","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2017","63","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2018","63","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2019","63","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2020","64","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2021","59","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2022","59","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","422","Lebanon","2023","53","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2001","46","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2002","50","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2003","47","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2004","56","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2005","68","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2006","80","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2007","80","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2008","80","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2009","81","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2010","81","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2012","82","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2013","82","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2014","82","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2016","82","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2018","82","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2019","82","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2020","82","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2022","75","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","426","Lesotho","2023","82","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2000","90","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2001","95","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2005","99","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2011","92","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2017","89","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2020","94","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2021","85","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","428","Latvia","2023","92","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2019","13","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2020","30","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2021","35","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2022","59","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","430","Liberia","2023","60","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2000","12","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2001","13","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2002","13","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2003","12","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2004","13","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2005","12","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2006","12","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2007","10","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2008","11","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2009","11","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2010","13","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2011","15","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2012","15","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2013","18","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2014","21","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2015","26","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2016","34","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2017","37","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2018","40","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2019","49","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2020","51","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2021","53","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2022","57","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","432","Landlocked developing countries (LLDCs)","2023","59","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2001","81","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2002","86","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2003","90","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2013","95","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2015","97","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2016","96","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2019","72","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2021","72","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","434","Libya","2023","72","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2000","97","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2001","96","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2002","95","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2003","93","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2004","93","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2006","94","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2009","94","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2019","93","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2021","88","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","440","Lithuania","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2012","86","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2015","86","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2017","86","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2020","90","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2022","90","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","442","Luxembourg","2023","90","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2020","14","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2021","24","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2022","32","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","450","Madagascar","2023","47","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2015","8","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2016","61","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2018","72","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2019","75","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2020","75","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2021","74","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2022","60","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","454","Malawi","2023","65","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2005","91","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2006","90","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2008","93","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2009","95","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2018","88","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2019","87","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2020","84","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","458","Malaysia","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2007","56","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2008","76","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2010","96","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2014","97","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2021","98","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","462","Maldives","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2019","4","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2020","26","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2021","33","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2022","44","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","466","Mali","2023","59","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2003","2","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2004","31","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2005","60","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2006","86","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2007","77","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2008","83","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2009","85","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2010","85","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2011","85","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2021","93","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2022","95","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","470","Malta","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","478","Mauritania","2023","24","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2004","80","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2005","78","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2006","85","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2007","80","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2008","83","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2009","85","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2010","90","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2011","89","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2013","85","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2014","85","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2020","87","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","480","Mauritius","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2000","98","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2002","89","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2004","97","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2006","91","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2007","85","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2008","94","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2010","91","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2012","92","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2016","98","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2017","62","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2019","55","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2020","79","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2021","97","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2022","82","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","484","Mexico","2023","74","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2014","79","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2015","79","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2016","79","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2017","79","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2018","79","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2019","79","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2020","80","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2021","80","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2022","80","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","492","Monaco","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2000","75","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2001","95","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2007","97","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2009","97","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2013","97","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2014","98","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2016","90","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2017","98","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2018","98","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2020","96","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2021","94","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","496","Mongolia","2023","96","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2002","69","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2003","96","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2009","98","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2015","90","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2017","92","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2020","93","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2022","93","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","498","Republic of Moldova","2023","93","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2008","96","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2011","97","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2012","97","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2013","94","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2016","86","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2017","83","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2018","86","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2019","81","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2020","76","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2022","70","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","499","Montenegro","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2004","91","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2005","92","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2006","92","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2014","54","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","504","Morocco","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2016","39","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2017","43","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2018","48","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2019","55","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2020","47","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2021","38","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2022","38","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","508","Mozambique","2023","44","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2002","98","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2005","97","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2008","98","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2015","98","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2022","98","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","512","Oman","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2000","60","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2001","62","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2002","69","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2003","70","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2004","73","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2005","74","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2006","75","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2007","76","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2008","76","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2009","75","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2010","79","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2011","80","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2012","84","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2018","91","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2021","91","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","513","Europe and Northern America","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2000","52","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2001","55","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2002","61","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2003","62","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2004","67","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2005","68","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2006","69","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2007","69","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2008","76","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2009","77","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2010","81","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2011","82","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2012","85","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2014","89","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2015","89","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2019","92","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2020","92","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2021","92","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2022","91","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","514","Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)","2023","91","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2000","13","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2001","15","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2002","15","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2003","15","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2004","16","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2005","28","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2006","30","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2007","31","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2008","33","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2009","36","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2010","37","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2011","44","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2012","48","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2013","52","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2014","55","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2015","60","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2016","64","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2017","65","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2019","68","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2020","69","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2021","68","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2022","71","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","515","Developing regions","2023","72","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2017","32","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2018","50","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2019","56","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2020","63","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2021","56","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","516","Namibia","2023","62","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2001","95","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2002","83","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2003","72","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2004","60","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2005","50","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2006","97","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2009","92","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2012","81","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2014","94","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2015","96","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2016","97","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2017","94","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2018","94","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2020","97","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","520","Nauru","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2016","25","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2017","59","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2018","69","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2021","87","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2022","87","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","524","Nepal","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2002","96","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2003","98","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2005","93","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2006","92","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2007","92","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2008","93","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2009","93","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2010","92","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2011","93","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2012","93","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2013","92","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2014","93","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2018","89","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2020","89","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2021","90","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","528","Netherlands (Kingdom of the)","2023","81","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2000","1","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2001","1","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2002","4","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2003","4","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2004","4","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2005","9","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2006","10","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2007","11","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2008","10","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2009","10","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2010","10","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2011","11","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2012","10","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2013","11","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2014","10","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2015","10","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2016","9","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2017","9","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2018","12","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2019","28","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2020","32","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2021","26","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2022","34","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","543","Oceania (exc. Australia and New Zealand)","2023","45","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2022","NaN","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","548","Vanuatu","2023","21","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2011","86","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2012","85","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2013","86","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2014","86","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2015","87","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2016","89","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2017","90","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2018","90","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2019","90","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2020","91","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2021","82","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2022","83","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","554","New Zealand","2023","84","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2017","84","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2020","98","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2021","83","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","558","Nicaragua","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2014","3","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2015","16","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2016","31","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2017","46","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2018","48","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2019","58","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2020","60","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2021","66","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2022","42","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","562","Niger","2023","68","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2019","9","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2020","38","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2021","38","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2022","38","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","566","Nigeria","2023","38","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2000","99","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2001","99","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2002","90","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2003","86","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2004","99","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2005","70","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2007","99","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2008","99","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2010","99","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2011","98","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2012","98","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2014","99","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2015","99","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2016","99","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2017","99","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2019","99","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2020","99","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","570","Niue","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2000","90","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2001","90","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2002","90","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2003","89","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2004","90","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2005","91","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2006","91","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2007","93","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2009","96","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2010","97","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2011","94","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2012","91","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2013","91","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2014","92","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2016","91","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2017","91","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2018","93","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2019","95","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2022","94","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","578","Norway","2023","94","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2000","50","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2001","64","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2002","65","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2003","66","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2004","74","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2005","84","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2006","85","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2007","86","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2008","84","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2009","82","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2010","75","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2011","75","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2012","70","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2013","75","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2014","75","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2015","74","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2016","45","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2017","52","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2018","48","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2019","52","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2020","62","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2021","38","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2022","38","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","583","Micronesia (Federated States of)","2023","59","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2000","6","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2001","6","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2002","70","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2003","90","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2004","92","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2005","71","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2006","60","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2007","91","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2008","79","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2009","66","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2010","90","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2011","74","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2012","58","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2013","56","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2014","53","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2015","70","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2016","49","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2017","62","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2018","61","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2019","64","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2021","58","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2022","54","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","584","Marshall Islands","2023","61","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2000","75","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2001","83","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2002","90","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2003","94","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2004","98","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2005","95","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2006","98","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2007","83","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2008","77","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2009","79","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2010","39","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2011","83","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2012","86","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2013","98","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2014","81","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2015","82","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2017","77","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2018","75","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2019","88","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2020","83","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2021","84","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2022","85","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","585","Palau","2023","89","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2009","30","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2010","34","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2011","38","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2012","42","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2013","43","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2014","48","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2015","54","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2016","67","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2020","77","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2021","79","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2022","79","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","586","Pakistan","2023","80","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2000","88","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2001","88","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2002","88","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2003","89","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2004","89","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2005","89","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2006","86","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2007","83","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2008","79","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2009","76","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2010","73","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2011","81","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2012","72","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2013","68","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2014","90","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2015","92","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2018","99","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2019","97","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2020","74","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2021","75","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2022","75","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","591","Panama","2023","73","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2019","20","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2020","27","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2021","20","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2022","25","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","598","Papua New Guinea","2023","41","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2005","31","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2006","61","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2007","74","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2008","84","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2009","77","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2010","77","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2011","78","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2012","75","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2013","76","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2014","76","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2015","72","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2016","87","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2017","82","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2018","83","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2019","83","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2021","67","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2022","53","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","600","Paraguay","2023","57","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2007","9","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2008","17","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2009","42","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2010","56","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2011","70","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2012","63","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2013","54","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2014","44","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2015","63","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2016","68","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2017","67","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2018","67","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2019","66","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2020","52","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2021","60","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2022","54","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","604","Peru","2023","66","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2009","19","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2010","10","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2011","36","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2012","42","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2013","54","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2014","54","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2015","57","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2016","62","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2017","64","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2018","65","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2019","70","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2020","68","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2021","55","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2022","64","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","608","Philippines","2023","69","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2000","96","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2001","96","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2002","97","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2005","90","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2006","99","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2007","98","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2008","97","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2009","95","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2010","94","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2011","95","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2012","95","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2013","93","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2015","94","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2016","93","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2018","92","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2019","91","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2020","86","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2021","86","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2022","86","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","616","Poland","2023","86","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2000","48","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2001","56","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2002","64","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2003","72","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2004","79","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2005","87","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2006","95","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2007","95","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2009","95","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2010","95","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2011","96","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2012","96","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2013","96","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2014","96","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2015","95","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2016","95","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2017","95","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2018","96","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2019","96","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2020","95","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2021","95","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2022","96","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","620","Portugal","2023","95","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2016","NaN","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2017","NaN","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2018","NaN","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2019","NaN","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2020","NaN","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2021","NaN","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2022","1","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","624","Guinea-Bissau","2023","36","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2002","NaN","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2003","NaN","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2004","NaN","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2005","NaN","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2006","NaN","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2007","NaN","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2008","NaN","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2009","NaN","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2010","NaN","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2011","NaN","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2012","NaN","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2013","NaN","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2016","30","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2017","74","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2018","74","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2019","74","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2020","72","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2021","72","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","626","Timor-Leste","2023","72","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2000","NaN","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2001","NaN","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2002","91","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2003","91","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2004","95","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2005","98","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2006","87","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2007","91","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2009","99","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2010","98","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2011","99","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2012","99","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2013","99","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2014","95","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2015","91","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2016","92","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2017","93","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2018","95","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2019","98","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2020","88","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2021","99","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2022","99","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","634","Qatar","2023","99","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2000","96","2000",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2001","97","2001",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2002","97","2002",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2003","97","2003",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2004","96","2004",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2005","96","2005",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2006","96","2006",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2007","96","2007",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2008","95","2008",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2009","94","2009",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2010","93","2010",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2011","91","2011",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2012","90","2012",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2013","88","2013",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2014","84","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2015","80","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2016","76","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2017","75","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2018","81","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","642","Romania","2019","76","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2014","NaN","2014",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","180","Democratic Republic of the Congo","2015","NaN","2015",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,"MCV2 have not been introduced in the national immunization schedule in the given country (or  group of countries)","N","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2016","58","2016",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2017","64","2017",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2018","65","2018",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2019","66","2019",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2020","66","2020",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2021","69","2021",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2022","72","2022",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]
["3","3.b","3.b.1","SH_ACS_MCV2","Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)","894","Zambia","2023","75","2023",null,null,null,null,"WHO/UNICEF coverage estimates 2023 revision, July 2024",null,null,"E","G","PERCENT"]